Finally, based on the above results showing that AKT contributes to maintain constitutive N1-ICD levels, and other evidence that N1-ICD levels are increased by BCR activation in CLL cells [20, 21], we hypothesized that AKT also contributed to BCR-induced N1-ICD levels. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.